Skip to main content

Janssen Pharmaceutical companies of Johnson & Johnson - Accelerating R&D with disruptive technology

Significant advances in computational methodologies and platforms, together with hardware, has accelerated scientific computing, enabling the dawn of a new era of medicine. Today, lifesaving therapeutic molecules can be designed and optimized with greater speed and precision than ever before. Find out how Johnson & Johnson is leveraging collective institutional knowledge across therapeutic programs and indications to accelerate the development of lifesaving therapies for patients across the globe.